SJM Stock Gains 6% on Q2 Earnings Beat, Improved Volume/Mix

26.11.24 17:19 Uhr

Werte in diesem Artikel
Aktien

101,00 EUR 3,00 EUR 3,06%

3.400,00 KRW -5,00 KRW -0,15%

The J. M. Smucker Company SJM posted robust second-quarter fiscal 2025 results, wherein both the top and bottom lines increased year over year and beat the Zacks Consensus Estimate. Shares of the company rose nearly 6% in the pre-market trading session on Tuesday.The company's strong fiscal second-quarter performance reflects the resilience of its categories and the effective execution of key growth strategies. Organic net sales and earnings growth were driven by strong contributions from brands such as Uncrustables, Meow Mix, Cafe Bustelo and Jif.The company remains committed to delivering on its strategic priorities, including the integration and growth of Hostess Brands. The recent decision to divest the Voortman business further underscores the strategy of channeling resources toward the most significant growth opportunities.SJM’s Quarterly Performance: Key Metrics and InsightsAdjusted earnings of $2.76 per share improved 7% year over year and surpassed the Zacks Consensus Estimate of $2.51.The J. M. Smucker Company Price, Consensus and EPS Surprise The J. M. Smucker Company price-consensus-eps-surprise-chart | The J. M. Smucker Company QuoteFind the latest EPS estimates and surprises on Zacks Earnings Calendar.Net sales amounted to $2,271.2 million, which jumped 17% year over year while beating the Zacks Consensus Estimate of $2,267 million. Excluding acquisitions, divestitures, as well as currency movements, net sales grew 2%. The uptick in comparable net sales can be attributed to the higher volume/mix (up 2%) and net price realization (up 1%).The gross profit went up 22% due to the improved volume mix, better net price realization, reduced costs and a positive impact of the Hostess Brands acquisition, partly negated by the impact of divestitures. The adjusted gross profit grew 17%.The adjusted operating income jumped 27% year over year to $490.6 million.Decoding SJM’s Segmental PerformanceU.S. Retail Pet Foods: The segment’s sales fell 4% to $445.4 million. The volume/mix and net price realization had a two-percentage-point adverse impact each on net sales. The segment’s profit surged 25% to $121.4 million.U.S. Retail Coffee: The segment’s sales grew 3% to $704 million, backed by higher net price realization, while volume/mix remained neutral. The segment’s profit rose 19% to $202.7 million.U.S. Retail Frozen Handheld and Spreads: Sales in the segment increased 5% to $485.2 million. Excluding noncomparable sales in the year-ago period related to the divested Sahale Snacks business, net sales grew 6%. The volume/mix boosted net sales by 8%, and the net price realization lowered net sales by 2%. The segment’s profit tumbled 10% to $116.1 million.Sweet Baked Snacks: Sales in the segment came in at $315.5 million, with the segment profit amounting to $70.6 million in the quarter.International and Away from Home: Net sales dropped 1% to $321.1 million. Excluding the impact of noncomparable net sales associated with divestitures and currency movements, net sales grew 6%. The volume/mix had a two-percentage-point positive effect, and the net price realization had a positive impact of four percentage points on net sales. The segment’s profit increased 13% to $68 million.SJM’s Financial Health SnapshotThe J. M. Smucker exited the quarter with cash and cash equivalents of $49.2 million, long-term debt (net of current portion) of $6,776.8 million and total shareholders’ equity of $7,633.1 million.Cash flow provided by operating activities amounted to $404.2 million for the three months ended Oct. 31, 2024. Free cash flow was $317.2 million in the same time frame.Free cash flow and capital expenditures are likely to be $875 million and $450 million, respectively, in fiscal 2025.What to Expect From SJM in Fiscal 2025?For fiscal 2025, SJM anticipates comparable net sales to increase by nearly 1-2% compared with the earlier view of 0.5-1.5%. This view also includes a decrease of $100 million contract manufacturing sales associated with the divested pet food brands.Fiscal 2025 net sales are still anticipated to increase 8.5-9.5%. The adjusted EPS for fiscal 2025 is now envisioned in the $9.70-$10.10 band, up from the $9.60-$10 band range expected before. The company recorded an adjusted EPS of $9.94 in fiscal 2024. The bottom-line guidance takes into account an adjusted gross profit margin of 37.5%-38% and a roughly 9% rise in SD&A expenses. The company had earlier expected the adjusted gross margin to be 37.5%.Management’s fiscal 2025 guidance does not incorporate any effects from the previously announced deal to offload the Voortman business. This transaction, anticipated to close in the third quarter of fiscal 2025, is expected to impact fiscal 2025 net sales by approximately $65 million and adjusted earnings per share by around 10 cents. The company plans to allocate the proceeds toward debt reduction and projects that the earnings impact will remain negligible to the fiscal 2025 adjusted EPS guidance range.Shares of this Zacks Rank #3 (Hold) company have risen 3.5% over the past six months against the industry’s decline of 4.5%.Top Three Consumer Staple PicksIngredion Incorporated INGR manufactures and sells sweeteners, starches, nutrition ingredients and biomaterial solutions derived from wet milling and processing corn and other starch-based materials. The company currently sports a Zacks Rank #1 (Strong Buy). INGR has a trailing four-quarter earnings surprise of 9.5%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Ingredion’s current financial year’s earnings indicates growth of 12.5% from the year-ago reported number.Freshpet Inc. FRPT manufactures, distributes and markets natural fresh meals and treats for dogs and cats. It currently carries a Zacks Rank #2 (Buy). FRPT has a trailing four-quarter earnings surprise of 144.5%, on average.The Zacks Consensus Estimate for Freshpet’s current financial-year sales and earnings implies growth of 27.3% and 224.3%, respectively, from the prior-year reported levels.McCormick & Company MKC, which manufactures, markets and distributes spices, seasoning mixes, condiments and other flavorful products, currently carries a Zacks Rank #2. MKC has a trailing four-quarter earnings surprise of 13.8%, on average.The Zacks Consensus Estimate for McCormick’s current fiscal-year sales and earnings indicates growth of 0.6% and 8.2%, respectively, from the prior-year reported levels.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The J. M. Smucker Company (SJM): Free Stock Analysis Report Freshpet, Inc. (FRPT): Free Stock Analysis Report McCormick & Company, Incorporated (MKC): Free Stock Analysis Report Ingredion Incorporated (INGR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Q2 Holdings Inc

Analysen zu Q2 Holdings Inc

DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
11.05.2018Q2 NeutralBTIG Research
DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
16.02.2018Q2 BuyNeedham & Company, LLC
DatumRatingAnalyst
11.05.2018Q2 NeutralBTIG Research
18.11.2016Q2 Sector WeightPacific Crest Securities Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"